Digital Transformation: Where are we going wrong? Exploring the slow pace of adoption of novel technologies within biopharma R&D
From the beta amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s... Read more
LIMS of the Future In LIMS of the Future, we discussed the tools, technologies and infrastructure needed to support a... Read more
LIMS of the future REGISTER HERE Lab of the Future’s exciting new Digital Dialogue session is coming up on... Read more